At Long Last, Dynavax Wins FDA Approval For Heplisav By: Benzinga via Benzinga November 10, 2017 at 08:44 AM EST Dynavax Technologies Corporation (NASDAQ: DVAX), a clinical-stage immunotherapy company, confirmed on Thursday the U.S. Food and Drug ... Read More >> Related Stocks: Dynavax Technologies